At Tri Valley Plastic Surgery, the advertised route into weight-management care is through a local surgical and Med Spa practice—not a clearly documented mail-order subscription. Patients can request an in-person or virtual consultation, and the practice describes monthly appointments alongside medication pickup. That combination makes the handoff between consultation, prescribing and receiving medication especially important: who evaluates you, what product you receive, and what happens between visits are separate questions.
This review follows that care pathway using public documentation consulted October 19, 2026. Tri Valley explicitly offers semaglutide and tirzepatide, publishes first-month and subsequent-month prices, and describes ongoing monitoring. Those are useful starting points. However, the consulted pages do not identify the dispensed products or pharmacy, explain a home-delivery process, or provide complete billing and cancellation terms. The central issue is not whether the practice advertises treatment—it does—but how much of the treatment process a prospective patient can verify before enrolling.
At a glance
- Practice and location
- Tri Valley Plastic Surgery is a Dublin, California, surgical and Med Spa practice that explicitly advertises semaglutide and tirzepatide.
- Initial clinical contact
- The semaglutide page describes an initial consultation with a physician assistant and says Steven Williams oversees that program.Sources: [6]
- Published semaglutide charges
- The initial consultation is $50; medication is advertised at $500 for the first month and $600 for each subsequent month.Sources: [6]
- Published tirzepatide charges
- Tirzepatide is advertised at $700 for the first month and $800 for each subsequent month; four- and seven-month packages are also offered.Sources: [7]
Start with the local practice, not a nationwide telehealth assumption
Tri Valley presents itself as a plastic surgery practice in Dublin serving the Bay Area and patients from elsewhere, including internationally. Its main office is listed at 11820 Dublin Blvd, Dublin, CA 94568, with Monday–Friday hours of 8 a.m.–5 p.m. The Med Spa is listed separately at 11828 Dublin Blvd. Those nearby but distinct addresses matter when arranging an assessment or collecting medication: the booking confirmation should identify the correct destination.
The Med Spa advertises Monday–Wednesday hours of 8 a.m.–5 p.m., Thursday hours until 7 p.m., Friday hours until 6 p.m., and Saturday hours of 9 a.m.–5 p.m. The weight-loss booking page also advertises extended-hours medication pickup. It does not establish that every Med Spa opening hour is a pickup window, however. Confirm the pickup location, whether an appointment is required, and whether medication must be requested in advance before making the trip.
Virtual consultations are expressly available, but that does not establish nationwide prescribing or treatment availability outside California. The practice’s broader statement about serving international patients likewise does not define GLP-1 telehealth eligibility. For a prospective patient, the useful first distinction is between being able to request a remote conversation and being able to receive ongoing treatment where they live. Our guide to the GLP-1 care journey explains why those stages should be checked separately.
Booking leads to an assessment, not a guaranteed prescription
The booking page directs prospective patients to consult a weight-loss provider for a $50 consultation fee. Anyone preferring a virtual meeting is asked to say so in the notes. If available appointments do not work, the listed scheduling number is (925) 875-9011. Separately, the website lists (925) 875-0700 for discussing accessibility accommodations related to using the site; that number should not be mistaken for a dedicated clinical or urgent-care contact.
For semaglutide, the initial visit is described as a meeting with a PA—a physician assistant—to discuss weight-loss goals and medical history. The practice says its assessment considers individual health needs and potential underlying issues affecting weight management. Its tirzepatide description similarly refers to reviewing health history, goals and lifestyle. These statements outline an evaluative process, but the consulted pages do not publish complete screening criteria, required tests, age limits or contraindication procedures.
Both medication pages discuss treatment for people without diabetes. That is a provider statement about the potential patient population, not an assurance that any particular applicant qualifies. The semaglutide page says a patient may leave with medication if the assessment is favorable; the conditional wording matters. Before paying, ask what the consultation covers, what additional records or testing may be needed, and what charges apply if medication is not prescribed. Our first-consultation preparation guide offers a framework for organizing those questions.
Clinical oversight is named; the pharmacy handoff is not
The semaglutide page specifically states that Steven Williams oversees the program. The practice describes Williams as a board-certified plastic and reconstructive surgeon and a diplomate of the American Board of Plastic Surgery. It also presents Philip Wasicek as a double board-certified plastic surgeon focused on facial aesthetic surgery. These are provider-reported credentials, not independently verified findings here. Wasicek’s presence on the practice team does not, by itself, establish a role in prescribing or supervising its weight-management treatment.
More importantly for receiving medication, the public pages identify ingredient names without identifying the actual products dispensed. They do not establish a brand, manufacturer, presentation, dispensing pharmacy or whether either offering is compounded. A reference to “Ozempic face” elsewhere in the practice’s material is not confirmation that Ozempic is supplied. Patients should request the exact prescription product and pharmacy details rather than infer them from an ingredient name, a cosmetic discussion or a general approval claim.
FDA approval belongs to a specific product, not to a clinic. Compounded preparations are not FDA approved and do not undergo FDA premarket review for safety, effectiveness and quality; that fact alone does not demonstrate clinical inequivalence. FDA recommends compounded drugs when an individual’s medical needs cannot be met by an approved drug, with a prescription and a state-licensed pharmacy. Because Tri Valley’s product status is unresolved in the consulted documentation, our product-and-pharmacy checklist is particularly relevant before accepting medication.
Receiving medication: pickup is documented, shipping is not
The booking page says, “Receive your shots at monthly appointments,” and also offers extended-hours medication pickup. The semaglutide page adds that a patient may leave the initial visit with medication. Together, these passages document possible local access, but they do not fully explain administration. A monthly appointment interval is not a dosing instruction, and the pages do not specify the anatomical injection route, who administers each injection, or how much medication is provided at a pickup.
The missing operational details matter whether treatment occurs in the office or continues at home. Ask who dispenses the medicine, what container or device is supplied, whether supplies and instruction are included, and whom to contact about a label or measurement question. FDA has received reports of errors measuring or administering compounded medication, including some associated with hospitalization. Instructions should therefore come from the prescriber or pharmacist—not from interpreting this review or extrapolating from another patient’s prescription.
No home-shipping pathway, transportation charge, dispatch schedule, arrival estimate or cold-chain procedure is established in the consulted pages. Virtual consultation should not be read as an implicit promise of delivery. If shipping is offered during enrollment, obtain those details separately. FDA explicitly advises not using an injectable GLP-1 drug that arrives warm or with insufficient refrigeration and contacting the provider or dispensing pharmacy to resolve the concern. That is general FDA guidance, not evidence of a delivery problem at Tri Valley.
Monthly prices do not fully define the monthly service
Tri Valley publishes concrete medication prices rather than only inviting readers to request a quote. Semaglutide is advertised at $500 for the first month and $600 for each subsequent month, with a separate $50 initial consultation fee. Tirzepatide is advertised at $700 for the first month and $800 for each subsequent month. The booking page also lists a $50 consultation, but the tirzepatide pricing passage does not independently clarify how that fee applies to its enrollment.
The pages use months, not four-week billing periods. They do not specify the exact formulation, presentation or quantity associated with these charges, or clearly itemize whether follow-ups, tests and supplies are included. Both programs advertise four- and seven-month packages without publishing package prices or complete payment conditions. Those durations do not establish a medication quantity, mandatory prepayment or minimum commitment. Financing is available, with semaglutide details and a payment calculator offered on request and tirzepatide details discussed during consultation.
A written service breakdown is more useful than assuming the monthly medication price covers the entire care pathway. Ask when payment is collected, whether subsequent charges occur automatically, what follow-up costs, and what happens financially if treatment changes or ends. Insurance coverage and claim submission are not established for these programs. Nor do the consulted pages supply treatment-specific cancellation, refund, pause or unused-medication terms. Website-access termination language is not a substitute for a treatment cancellation policy.
| Item | Published terms | Confirm before paying |
|---|---|---|
| Initial consultation | $50 on the booking and semaglutide pages | Application to tirzepatide and charges if no prescription results |
| Semaglutide medication | $500 first month; $600 each subsequent month | Exact product, quantity and included services |
| Tirzepatide | $700 first month; $800 each subsequent month | Exact product, quantity and any separate fees |
| Treatment packages | Four- and seven-month options for both programs | Package price, collection schedule and commitment terms |
| Financing | Available; details provided on request or during consultation | Eligibility, interest, fees and payment obligations |
Follow-up has a monthly cadence, but between-visit support needs clarification
The semaglutide program describes monthly follow-ups with providers to track progress. Tirzepatide documentation is more specific: after an initial prescription, patients return for monthly check-ins covering weight, blood sugar levels and other relevant indicators. This establishes an intended monitoring cadence. It does not establish which measurements are taken at every visit, which require laboratory testing, whether remote follow-ups are available, or who pays for tests that the treating clinician considers necessary.
Tri Valley also encourages regular physical activity and a balanced, nutritious diet alongside tirzepatide. That is not the same as documenting an included dietitian service, structured nutrition visits or individualized exercise support. NIDDK describes medication as accompanying healthy eating and physical activity, with follow-up addressing tolerance and response. For this practice, the practical question is which professional provides that ongoing review and what services are actually included rather than simply encouraged.
The consulted documentation does not publish a program-specific urgent contact route or response-time promise. Before starting, distinguish scheduling help from clinical messaging and ask how medication concerns are handled between monthly visits. Also ask who covers absences and whether additional clinical contacts carry fees. Our guide to ongoing GLP-1 support explains how to separate an appointment schedule from the broader responsibility to assess questions, tolerability and changing care needs.
The surgical and Med Spa connection creates separate decisions
Tri Valley advertises post-weight-loss services including skin tightening and body contouring. Those services fit its wider surgical and Med Spa business, but the pages do not establish that they are included in medication fees. The practice says it provides individualized quotes after a private physical assessment and medical review. Its published candidate characteristics for post-weight-loss procedures—including maintained weight loss, excess skin, good health and not smoking—belong to those procedures, not to the GLP-1 enrollment criteria.
A semaglutide promotion offers a credit of 50% of program expenses toward surgery after the patient reaches their target weight. The surgery must have a minimum surgeon fee of $5,000, and the maximum applicable credit is $3,600. This is a conditional credit toward another service, not a medication refund or an assurance of surgical eligibility. The consulted material does not state an expiration date, so availability and the full accounting rules require confirmation before relying on it.
A separate referral promotion offers $200 in credit when the referred patient enrolls in semaglutide. The credit may be applied toward treatments or services except skincare and neurotoxin banks; the practice says referrals can accumulate and the offer can combine with other promotions. Conversely, the $100 new-patient Med Spa discount expressly excludes weight-loss treatments and neurotoxin banks. Keeping these offers separate prevents a cosmetic-service promotion from being mistaken for a reduction in the published medication price.
What the documentation establishes—and what it cannot
The practice’s public materials establish a recognizable service outline: assessment, possible medication access and monthly monitoring within a broader aesthetic practice. They do not establish measured weight-loss outcomes for its program. Surgical, filler or Botox testimonials appearing on the site cannot answer how GLP-1 patients fare. Similarly, broader provider claims about cardiovascular or cancer-related benefits do not demonstrate those outcomes for Tri Valley patients or for an unidentified dispensed product.
Tri Valley’s website terms carry a January 1, 2026, update date and say its materials are general information rather than comprehensive documentation. That limitation is consistent with the gaps in the patient pathway. Before enrollment, request the exact medication and pharmacy, a written administration and pickup plan, the named follow-up contact, an itemized cost description, and treatment-specific cancellation terms. These are unresolved documentation questions—not proof that the practice lacks the corresponding services or policies.
Questions & answers
Can I have a virtual consultation with Tri Valley?
Yes. The semaglutide page offers virtual and in-person consultations, and the booking page asks patients to mention a virtual preference in the notes. This does not establish treatment availability in every state or medication shipping. Confirm whether the practice can provide continuing care where you live and whether any assessment, monitoring or pickup requires a visit to Dublin.
Who conducts the semaglutide assessment?
The semaglutide page describes meeting with a physician assistant to discuss medical history and weight-loss goals, with Steven Williams overseeing the program. It does not identify every clinician who may handle follow-up. Ask who will assess you, who will issue any prescription, and who will answer clinical questions between appointments rather than assuming all visits are with the overseeing surgeon.
Can I receive medication at the first appointment?
Possibly. The semaglutide page says patients may leave with medication if the assessment is favorable. That is not a guaranteed prescription or same-day supply promise. The booking page also advertises medication pickup and shots at monthly appointments. Ask what is available at your particular visit and obtain clear instructions about any medication intended for use outside the office.
Are follow-ups and laboratory tests included in the monthly price?
The consulted pages do not clearly itemize those inclusions. They publish medication prices and describe monthly follow-up, but those statements do not establish that visits, laboratory work and supplies are bundled into one charge. Request a written breakdown for the specific program. Also confirm whether the $50 consultation charge applies to your tirzepatide booking and whether additional clinical visits cost extra.
Does a four- or seven-month package require paying upfront?
The public descriptions do not establish that. Both programs offer four- and seven-month packages, but the consulted passages omit package prices, payment schedules and commitment conditions. Financing availability does not resolve those questions. Ask for the agreement, including cancellation, refunds, pauses and any financing obligations, before choosing a package. Package duration alone does not tell you the amount of medication supplied.
Does the semaglutide surgery promotion reduce my medication bill?
The documented offer is a later surgical credit, not a stated reduction in the medication bill. It offers 50% of semaglutide program expenses toward surgery after reaching target weight, subject to a minimum $5,000 surgeon fee and a $3,600 credit cap. Confirm current availability, qualifying expenses and other conditions. The separate $100 new-patient Med Spa offer excludes weight-loss treatments.
Our assessment
Tri Valley Plastic Surgery documents a locally anchored GLP-1 offering with useful specifics: two advertised medications, published first-month and subsequent-month charges, a semaglutide assessment with a physician assistant, named program oversight and monthly monitoring. Its local pickup option may be relevant to people who prefer an office-based relationship over an assumed shipping model. The unresolved details, however, sit at consequential handoffs: the exact product and dispensing pharmacy, administration responsibilities, between-visit support, included fees and treatment-specific exit terms. The public pages are enough to prepare for a consultation, but not enough to reconstruct the full service agreement. A prospective patient’s next step is to obtain those details in writing and separate medication care from optional cosmetic services and promotional credits.
This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.
Sources & documentation
Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.
- FDA concerns with unapproved GLP-1 drugs used for weight loss ↗
- NIDDK: prescription medications for overweight and obesity ↗
- Tri Valley Plastic Surgery — get started with weight loss ↗
- Tri Valley Plastic Surgery — weight loss shots/post weight loss ↗
- Tri Valley Plastic Surgery — about/about tri valley plastic surgery ↗
- Tri Valley Plastic Surgery — weight loss shots/semaglutide ↗
- Tri Valley Plastic Surgery — weight loss shots/tirzepatide ↗
- Tri Valley Plastic Surgery — weight loss shots/ozempic face ↗
- Tri Valley Plastic Surgery — official website ↗
- Tri Valley Plastic Surgery — terms and conditions ↗